Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma

被引:117
作者
Emami, B
Sethi, A
Petruzzelli, GJ
机构
[1] Loyola Univ, Med Ctr, Dept Radiat Oncol, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Otolaryngol, Maywood, IL 60153 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 57卷 / 02期
关键词
CT; MRI; image fusion; 3D-CRT; IMRT;
D O I
10.1016/S0360-3016(03)00570-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare CT and MRI target volumes for nasopharyngeal carcinoma (NPC) and evaluate the role of intensity-modulated radiotherapy (IMRT) in treating composite CT+MRI targets. Methods and Materials: CT and T-1/T-2-weighted MRI scans were obtained for 8 consecutive NPC patients. Using CT, MRI, and fused CT/MRI, various target volumes (gross target volume, clinical target volume, and planning target volume [PTV]) and critical structures were outlined. For each patient, three treatment plans were developed: (1) a three-dimensional conformal RT (3D-CRT) plan using CT-based targets; (2) a 3D-CRT plan using composite CT+MRI targets; and (3) a IMRT plan using CT+MRI targets. The prescription dose was 57.6 Gy and 70.2 Gy to the initial and boost PTV, respectively. Treatment plans were compared using the PTV dose to 95% volume (D-95), critical structure dose to 5% organ volume (D-5), and mean dose. Results: Compared with CT, the MRI-based targets were 74% larger, more irregularly shaped, and did not always include the CT targets. For CT-based targets, 3D-CRT plans, in general, achieved adequate target coverage and sparing of critical structures. However, when these plans were evaluated using CT+MRI targets, the average PTV D-95 was similar to60 Gy (14% underdosing), and critical structure doses were significantly worse. The use of IMRT for CT+MRI targets resulted in marked improvement in the PTV coverage and critical structure sparing: average PTV D-95 improved to 69.3 Gy, brainstem D-5 to <43 Gy (19% reduction), spinal cord D-5 to <37 Gy (19% reduction), and the mean dose to the parotids and cochlea reduced to below tolerance (23.7 Gy and 35.6 Gy, respectively). Conclusion: CT/MRI fusion improved the determination of target volumes in NPC. In contrast to 3D-CRT, IMRT planning resulted in significantly improved coverage of composite CT+MRI targets and sparing of critical structures. (C) 2003 Elsevier Inc.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 30 条
[1]   Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors [J].
Aoyama, H ;
Shirato, H ;
Nishioka, T ;
Hashimoto, S ;
Tsuchiya, K ;
Kagei, K ;
Onimaru, R ;
Watanabe, Y ;
Miyasaka, K .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (03) :821-827
[2]   Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: Results of a matched cohort analysis [J].
Chua, DTT ;
Sham, JST ;
Au, GKH ;
Choy, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (02) :334-343
[3]   THE VALUE OF MAGNETIC-RESONANCE-IMAGING IN TREATMENT PLANNING OF NASOPHARYNGEAL CARCINOMA [J].
CURRAN, WJ ;
HACKNEY, DB ;
BLITZER, PH ;
BILANIUK, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (12) :2189-2196
[4]   The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer [J].
Debois, M ;
Oyen, R ;
Maes, F ;
Verswijvel, G ;
Gatti, G ;
Bosmans, H ;
Feron, M ;
Bellon, E ;
Kutcher, G ;
Van Poppel, H ;
Vanuytsel, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (04) :857-865
[5]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[6]   INTEGRATION OF MAGNETIC-RESONANCE-IMAGING INTO RADIATION-THERAPY TREATMENT PLANNING .1. TECHNICAL CONSIDERATIONS [J].
FRAASS, BA ;
MCSHAN, DL ;
DIAZ, RF ;
TENHAKEN, RK ;
AISEN, A ;
GEBARSKI, S ;
GLAZER, G ;
LICHTER, AS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (12) :1897-1908
[7]   Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma [J].
Fu, KK .
SEMINARS IN RADIATION ONCOLOGY, 1998, 8 (04) :247-253
[8]  
HUANG SC, 1980, INT J RADIAT ONCOL, V6, P401
[9]   Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer [J].
Hunt, MA ;
Zelefsky, MJ ;
Wolden, S ;
Chui, CS ;
LoSasso, T ;
Rosenzweig, K ;
Chong, L ;
Spirou, SV ;
Fromme, L ;
Lumley, M ;
Amols, HA ;
Ling, CL ;
Leibel, SA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (03) :623-632
[10]  
*INT COMM RAD UN M, 1993, 50 INT COMM RAD UN M